Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page footer revision has been bumped to v3.6.3 from v3.6.2, signaling a small backend/template update rather than a change to trial details.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, indicating a minor site update; no study content or patient-facing information was changed.SummaryDifference0.1%

- Check17 days agoChange DetectedA large group of terms and section labels related to the study's interventions, regulatory status, eligibility criteria, and study metadata were removed from the study record. This reduces the visible content that defines what the study involves and its administrative timeline, potentially affecting searchability and user understanding.SummaryDifference16%

- Check25 days agoChange DetectedNew user-help/navigation sections were added: Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was updated and the Revision label changed to v3.6.0.SummaryDifference0.6%

- Check32 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the page, indicating a newer version of the page.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a minor update to the page. No substantive study content or user-facing changes are indicated by this revision.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.